Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 339

1.

Recombinant GroEL enhances protective antigen-mediated protection against Bacillus anthracis spore challenge.

Sinha K, Bhatnagar R.

Med Microbiol Immunol. 2013 Apr;202(2):153-65. doi: 10.1007/s00430-012-0280-z. Epub 2012 Dec 21.

PMID:
23263010
2.

Significant passive protective effect against anthrax by antibody to Bacillus anthracis inactivated spores that lack two virulence plasmids.

Enkhtuya J, Kawamoto K, Kobayashi Y, Uchida I, Rana N, Makino S.

Microbiology. 2006 Oct;152(Pt 10):3103-10.

PMID:
17005989
3.

The role of antibodies to Bacillus anthracis and anthrax toxin components in inhibiting the early stages of infection by anthrax spores.

Welkos S, Little S, Friedlander A, Fritz D, Fellows P.

Microbiology. 2001 Jun;147(Pt 6):1677-85.

PMID:
11390699
4.

Recombinant Bacillus anthracis spore proteins enhance protection of mice primed with suboptimal amounts of protective antigen.

Cybulski RJ Jr, Sanz P, McDaniel D, Darnell S, Bull RL, O'Brien AD.

Vaccine. 2008 Sep 8;26(38):4927-39. doi: 10.1016/j.vaccine.2008.07.015. Epub 2008 Jul 25.

5.

A plant based protective antigen [PA(dIV)] vaccine expressed in chloroplasts demonstrates protective immunity in mice against anthrax.

Gorantala J, Grover S, Goel D, Rahi A, Jayadev Magani SK, Chandra S, Bhatnagar R.

Vaccine. 2011 Jun 15;29(27):4521-33. doi: 10.1016/j.vaccine.2011.03.082. Epub 2011 Apr 17.

PMID:
21504775
6.

Poly-gamma-d-glutamic acid and protective antigen conjugate vaccines induce functional antibodies against the protective antigen and capsule of Bacillus anthracis in guinea-pigs and rabbits.

Lee DY, Chun JH, Ha HJ, Park J, Kim BS, Oh HB, Rhie GE.

FEMS Immunol Med Microbiol. 2009 Nov;57(2):165-72. doi: 10.1111/j.1574-695X.2009.00595.x. Epub 2009 Aug 6.

7.

An intranasal vaccine targeting both the Bacillus anthracis toxin and bacterium provides protection against aerosol spore challenge in rabbits.

Wimer-Mackin S, Hinchcliffe M, Petrie CR, Warwood SJ, Tino WT, Williams MS, Stenz JP, Cheff A, Richardson C.

Vaccine. 2006 May 1;24(18):3953-63. Epub 2006 Feb 28.

PMID:
16530302
8.

The detection of protective antigen (PA) associated with spores of Bacillus anthracis and the effects of anti-PA antibodies on spore germination and macrophage interactions.

Cote CK, Rossi CA, Kang AS, Morrow PR, Lee JS, Welkos SL.

Microb Pathog. 2005 May-Jun;38(5-6):209-25. Epub 2005 Apr 22.

PMID:
15925272
9.

Efficacy of a vaccine based on protective antigen and killed spores against experimental inhalational anthrax.

Gauthier YP, Tournier JN, Paucod JC, Corre JP, Mock M, Goossens PL, Vidal DR.

Infect Immun. 2009 Mar;77(3):1197-207. doi: 10.1128/IAI.01217-08. Epub 2008 Dec 29.

10.

Immunization against anthrax using Bacillus subtilis spores expressing the anthrax protective antigen.

Duc le H, Hong HA, Atkins HS, Flick-Smith HC, Durrani Z, Rijpkema S, Titball RW, Cutting SM.

Vaccine. 2007 Jan 4;25(2):346-55. Epub 2006 Aug 4.

PMID:
17007969
11.

Protective antigen and extractable antigen 1 based chimeric protein confers protection against Bacillus anthracis in mouse model.

Makam SS, Kingston JJ, Harischandra MS, Batra HV.

Mol Immunol. 2014 May;59(1):91-9. doi: 10.1016/j.molimm.2014.01.012. Epub 2014 Feb 8.

PMID:
24513572
12.

Protective effect of Bacillus anthracis surface protein EA1 against anthrax in mice.

Uchida M, Harada T, Enkhtuya J, Kusumoto A, Kobayashi Y, Chiba S, Shyaka A, Kawamoto K.

Biochem Biophys Res Commun. 2012 May 4;421(2):323-8. doi: 10.1016/j.bbrc.2012.04.007. Epub 2012 Apr 9.

PMID:
22507985
13.

Efficacious, nontoxigenic Bacillus anthracis spore vaccines based on strains expressing mutant variants of lethal toxin components.

Mendelson I, Gat O, Aloni-Grinstein R, Altboum Z, Inbar I, Kronman C, Bar-Haim E, Cohen S, Velan B, Shafferman A.

Vaccine. 2005 Dec 1;23(48-49):5688-97. Epub 2005 Feb 5.

PMID:
16039760
14.

Mucosal immunization with a novel nanoemulsion-based recombinant anthrax protective antigen vaccine protects against Bacillus anthracis spore challenge.

Bielinska AU, Janczak KW, Landers JJ, Makidon P, Sower LE, Peterson JW, Baker JR Jr.

Infect Immun. 2007 Aug;75(8):4020-9. Epub 2007 May 14.

15.

Anthrax spores make an essential contribution to vaccine efficacy.

Brossier F, Levy M, Mock M.

Infect Immun. 2002 Feb;70(2):661-4.

16.

CD1d-dependent B-cell help by NK-like T cells leads to enhanced and sustained production of Bacillus anthracis lethal toxin-neutralizing antibodies.

Devera TS, Aye LM, Lang GA, Joshi SK, Ballard JD, Lang ML.

Infect Immun. 2010 Apr;78(4):1610-7. doi: 10.1128/IAI.00002-10. Epub 2010 Feb 1.

17.

Increased long-term immunity to Bacillus anthracis protective antigen in mice immunized with a CIA06B-adjuvanted anthrax vaccine.

Wui SR, Han JE, Kim YH, Rhie GE, Lee NG.

Arch Pharm Res. 2013 Apr;36(4):464-71. doi: 10.1007/s12272-013-0034-5. Epub 2013 Feb 26.

PMID:
23440578
18.

Protection of mice against challenge with Bacillus anthracis STI spores after DNA vaccination.

Hahn UK, Alex M, Czerny CP, Böhm R, Beyer W.

Int J Med Microbiol. 2004 Jul;294(1):35-44.

PMID:
15293452
19.

Analysis of a novel spore antigen in Bacillus anthracis that contributes to spore opsonization.

Cote CK, Bozue J, Moody KL, DiMezzo TL, Chapman CE, Welkos SL.

Microbiology. 2008 Feb;154(Pt 2):619-32. doi: 10.1099/mic.0.2007/008292-0.

PMID:
18227265
20.

Supplemental Content

Support Center